Sources of information for assessing human papillomavirus vaccination history among young women

Vaccine

Volumn 32, Issue 25, 2014, Pages 2945-2947

  Niccolai, Linda M ^a   McBride, Vanessa ^a   Julian, Pamela R ^a   Meek, James ^a   Hadler, James ^a   Sosa, Lynn ^b   Hariri, Susan ^c   Markowitz, Lauri ^c  

^a YALE UNIVERSITY   (United States)

^b CDC   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Human papillomavirus virus (HPV); Medical records; Surveillance; Vaccination; Vaccine effectiveness; Vaccine impact

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; FEMALE; HUMAN; INFORMATION PROCESSING; INTERVIEW; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MEDICAL INFORMATION; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; SELF REPORT; UNITED STATES; VACCINATION;

HUMAN PAPILLOMAVIRUS VIRUS (HPV); MEDICAL RECORDS; SURVEILLANCE; VACCINATION; VACCINE EFFECTIVENESS; VACCINE IMPACT;

ADOLESCENT; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONNECTICUT; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; MEDICAL RECORDS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; POPULATION SURVEILLANCE; REGISTRIES; SELF REPORT; VACCINATION; YOUNG ADULT;

EID: 84899927406     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.03.059     Document Type: Article

References (7)

1. Markowitz L.E., Hariri S., Unger E.R., Saraiya M., Datta S.D., Dunne E.F. Post-licensure monitoring of HPV vaccine in the United States. Vaccine 2010, 28:4731-4737.
2. Centers for Disease Control and Prevention Recommendations on the use of quadrivalent human papillomavirus vaccine in males - Advisory Committee on Immunization Practices (ACIP), 2011. MMWR 2011, 60:1705-1708.
3. Centers for Disease Control and Prevention FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR 2010, 59:626-629.
4. Niccolai L.M., Julian P.J., Bilinski A., Mehta N.R., Meek J.I., Zelterman D., et al. Area-based poverty, racial, and ethnic disparities in cervical cancer precursor rates in Connecticut, 2008-2009. Am J Public Health 2013, 103:156-163.
5. Hariri S., Unger E.R., Powell S.E., Bauer H.M., Bennett N.M., Bloch K.C., et al. The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions. Cancer Causes Control 2012, 23:281-288.
6. Mehta N.R., Julian P.J., Meek J.I., Sosa L.E., Bilinski A., Hariri S., et al. Human papillomavirus vaccination history among women with precancerous cervical lesions: disparities and barriers. Obstet Gynecol 2012, 119:575-581.
7. Connecticut Department of Public and Health Reportable diseases and laboratory reportable significant findings: changes for 2008. Conn Epidemiol 2008, 28:1-3.